Praxis Precision Medicines (PRAX) Earnings Date & Reports
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PRAX is expected to report earnings to fall 93.30% to -22 cents per share on March 13
Q4'23
Est.
$-0.22
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.42
Q4'24
Missed
by $0.15
Q3'24
Missed
by $0.76
The last earnings report on August 04 showed earnings per share of -330 cents, missing the estimate of -325 cents. With 861.26K shares outstanding, the current market capitalization sits at 1.01B.